Back to search results

Meditation Practices for Relaxation in Cancer Survivors

This study is looking at how different types of meditation can help cancer survivors relax and feel more peaceful. It compares four meditation approaches: breathing only, focused attention only, mindfulness only, and a combination of all three. You might be able to join if you are 18 or older, can speak English or Spanish, and haven't had much previous training in mind-body relaxation techniques. The researchers want to see how well people stick with the meditation programs and how much each type of meditation helps improve relaxation. This study aims to understand which meditation technique works best for cancer survivors.

Study design
This interventional study is designed to enroll 44 participants who will be randomly assigned to one of four meditation groups.
What's involved
You would attend three 60-minute meditation sessions with an instructor over six weeks, practice meditation at home, and provide saliva samples.
Compensation
Not stated in the trial record.
Follow-up
The study measures retention and adherence rates for up to 6 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06500377

Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors

Recruiting
NAAges 18+InterventionalSupportive care
City of Hope Medical Center
~44 participants
Updated 2026-07-01 on ClinicalTrials.gov
What's tested:Biospecimen CollectionMeditation TherapyQuestionnaire Administration

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Retention rate
Measured over Up to 6 weeks
+1 more outcome measured

Conditions

Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

Explore related trials

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Where it's being run

2 sites across 1 states
California2

Study leadership

  • Richard T Lee · PRINCIPAL_INVESTIGATOR · City of Hope Medical Center

Who to contact

Richard T. Lee
[email protected]
949-671-4091
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Documented written informed consent of the participant
Age: ≥ 18 years
Ability to understand and fluently speak English or Spanish
No previous training in mind-body relaxation techniques including meditation, yoga, tai chi, qigong, guided imagery, mindfulness-based stress reduction, hypnosis, or cognitive behavior therapy, that exceeds 3 hours. Additionally, no regular practice of mind-body relaxation techniques, or formal experience with mind-body relaxation techniques within the past 12 months
Visual Analog Scale (VAS) anxiety score of \> 3 from a range from 0 to 10. A "0" means the lowest anxiety score and a "10" means the highest anxiety score
Long-term cancer survivors who received surgery to treat their cancer ( \> 6 months since last treatment) with no history of chemotherapy, radiation therapy, or other systemic therapy (e.g., hormonal therapy) and/or have completely recovered from surgery OR patients identified as having pre-cancerous lesions that have been surgically treated (e.g., colon polyp that has been removed)
Willingness to:
Provide salivary alpha-amylase sample
Complete stress tests and study questionnaires
Be monitored with a Bispectral Index (BIS) device

Exclusion

Inability to complete study required time and procedures as outlined in the study procedures section of the protocol
Must not have had previous serious illnesses that affect neurological functioning such as strokes, heart attacks, Parkinson disease, etc
Ongoing active psychiatric condition, depressive/bi-polar related disorders, anxiety, psychosis disorders, or substance use that may interfere with the study including panic disorder, major depression, schizophrenia, and bipolar disease
Active cancer
Cancer survivors who have received chemotherapy, radiation therapy, or any other systemic treatment (e.g., hormonal therapy)
Women who are pregnant

What this trial measures

  • Retention rateUp to 6 weeks

    Feasibility will be achieved if 70% of all enrolled participants attend at least 5 full visits within 6 weeks. Descriptive statistics will be generated.

  • Adherence rateUp to 6 weeks

    Feasibility will be achieved if 70% of all enrolled participants complete all assessments of the program within 6 weeks. Descriptive statistics will be generated.